Clinical Trial Update: Evaluating the Benefits of RSV Maternal Vaccination Using a Scottish National Dataset

View source ↗

Summary

Pfizer is evaluating the benefits of maternal RSV vaccination using Scotland's national health dataset, and the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infections

Drugs mentioned

• Pfizer RSV maternal vaccine (RSV maternal vaccine)

Snippet

Sponsor: Pfizer | Conditions: Respiratory Syncytial Virus Infections | Status: NOT_YET_RECRUITING